Coronavirus: Gilead to trial inhaled version of ‘appealing’ remdesivir in race for COVID-19 treatment

Adrian Ovalle

Gilead Sciences is to trial an inhaled version of remdesivir, a drug which it states shows guarantee in the treatment of COVID-19 The pharmaceutical business stated in an open letter that it would evaluate healthy volunteers for Stage 1 trials today, and objective to start them in August. Chairman and president Daniel O’Day stated: “If […]

The post Coronavirus: Gilead to trial inhaled version of ‘appealing’ remdesivir in race for COVID-19 treatment appeared first on World Weekly News.

Read more →

EU wants to pay in advance for promising vaccines

Sallie Anderson

The EU Commission wants member states’ assistance to pay a few of the expenses in advance for business dealing with prospective Covid-19 vaccines and safe and secure dosages for European residents. Under its “vaccine strategy” to exist next Wednesday (17 June), the EU executive strategies to sign agreements with pharmaceutical business dealing with possible vaccines […]

The post EU wants to pay in advance for promising vaccines appeared first on World Weekly News.

Read more →

Coronavirus: US vaccine trial shows promising early results, biotech firm says

Adrian Ovalle

A vaccine trial in the United States is revealing promising early information, after the vaccine apparently produced protective antibodies in a little group of healthy volunteers. 8 people took part in the safety trial by Moderna, which began in March, and the vaccine was revealed to be safe while all individuals produced antibodies, the biotech […]

The post Coronavirus: US vaccine trial shows promising early results, biotech firm says appeared first on World Weekly News.

Read more →